Abstract
The current biopharmaceutical industry depends on the development of bioinformatics in the search and optimization of the properties of drugs. Compounds and their derivatives, whose metabolism influence, stability, and immunogenicity are confirmed by analytical and computational tools, are the candidates for becoming the drugs against antibodies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
